Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 35,1x - 38,8x | 37,0x |
| Selected Fwd EBIT Multiple | 29,2x - 32,2x | 30,7x |
| Fair Value | 25.591₹ - 28.233₹ | 26.912₹ |
| Upside | -16,3% - -7,7% | -12,0% |
| Benchmarks | Ticker | Full Ticker |
| Glenmark Pharmaceuticals Limited | 532296 | BSE:532296 |
| Lupin Limited | 500257 | BSE:500257 |
| Mankind Pharma Limited | 543904 | BSE:543904 |
| Alembic Pharmaceuticals Limited | 533573 | BSE:533573 |
| Medico Remedies Limited | 540937 | BSE:540937 |
| Abbott India Limited | ABBOTINDIA | NSEI:ABBOTINDIA |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 532296 | 500257 | 543904 | 533573 | 540937 | ABBOTINDIA | ||
| BSE:532296 | BSE:500257 | BSE:543904 | BSE:533573 | BSE:540937 | NSEI:ABBOTINDIA | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 2.8% | 10.1% | 19.9% | -2.3% | 39.4% | 18.4% | |
| 3Y CAGR | -5.6% | 16.5% | 10.6% | -20.1% | 40.8% | 16.7% | |
| Latest Twelve Months | 132.5% | 71.4% | 23.1% | 17.0% | 15.2% | 13.7% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 13.6% | 10.1% | 21.2% | 14.7% | 4.4% | 21.2% | |
| Prior Fiscal Year | 9.8% | 5.1% | 18.2% | 7.7% | 4.9% | 21.1% | |
| Latest Fiscal Year | 11.4% | 13.9% | 20.8% | 10.6% | 6.9% | 23.6% | |
| Latest Twelve Months | 18.7% | 18.8% | 21.1% | 11.2% | 6.6% | 24.4% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 2.98x | 4.38x | 8.11x | 2.98x | 2.76x | 10.33x | |
| EV / LTM EBITDA | 13.5x | 18.9x | 32.6x | 19.8x | 33.2x | 41.6x | |
| EV / LTM EBIT | 15.9x | 23.3x | 38.4x | 26.6x | 41.7x | 42.4x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 15.9x | 26.6x | 41.7x | ||||
| Historical EV / LTM EBIT | 37.4x | 39.1x | 42.8x | ||||
| Selected EV / LTM EBIT | 35.1x | 37.0x | 38.8x | ||||
| (x) LTM EBIT | 15,210 | 15,210 | 15,210 | ||||
| (=) Implied Enterprise Value | 533,939 | 562,041 | 590,143 | ||||
| (-) Non-shareholder Claims * | 10,452 | 10,452 | 10,452 | ||||
| (=) Equity Value | 544,391 | 572,493 | 600,595 | ||||
| (/) Shares Outstanding | 21.2 | 21.2 | 21.2 | ||||
| Implied Value Range | 25,619.24 | 26,941.73 | 28,264.22 | ||||
| FX Rate: INR/INR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 25,619.24 | 26,941.73 | 28,264.22 | 30,591.50 | |||
| Upside / (Downside) | -16.3% | -11.9% | -7.6% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 532296 | 500257 | 543904 | 533573 | 540937 | ABBOTINDIA | |
| Enterprise Value | 412,758 | 944,863 | 950,877 | 187,214 | 3,836 | 639,596 | |
| (+) Cash & Short Term Investments | 18,202 | 29,123 | 47,267 | 1,290 | 15 | 11,057 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (17,808) | (34,425) | (4,821) | (10,664) | (114) | (605) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 413,152 | 939,561 | 993,324 | 177,840 | 3,737 | 650,048 | |
| (/) Shares Outstanding | 282.2 | 456.5 | 412.6 | 196.6 | 83.0 | 21.2 | |
| Implied Stock Price | 1,464.10 | 2,058.00 | 2,407.60 | 904.75 | 45.03 | 30,591.50 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,464.10 | 2,058.00 | 2,407.60 | 904.75 | 45.03 | 30,591.50 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |